|
|
 Previous Article | Table of Contents | Next Article 
Blood, Vol. 89 No. 12 (June 15), 1997:
pp. 4600-4607
Cyanocobalamin [c-lactam] Inhibits Vitamin B12 and Causes Cytotoxicity in HL60 Cells: Methionine Protects Cells Completely
By
J.H. Matthews
From the Department of Medicine, Queen's University, Kingston, Ontario, Canada.
 |
ABSTRACT |
The [c-lactam] derivative of cobalamin antagonizes vitamin B12 in vivo. Therefore, we investigated its effects in tissue culture to develop a model in which to study vitamin B12-deficient hemopoiesis. HL60 cells were cultured in medium containing either methionine or L-homocysteine thiolactone, and various concentrations of 5-methyltetrahydrofolate or pteroylglutamic acid. In medium with L-homocysteine thiolactone, 5-methyltetrahydrofolate, and dialyzed serum, cyanocobalamin [c-lactam] caused cell death, reversible by additional vitamin B12 . Pteroylglutamic acid did not prevent this cytotoxic effect. Methionine completely protected cells against cyanocobalamin [c-lactam] for periods of up to 4 months of culture, irrespective of the folate source. Cyanocobalamin [c-lactam] reversibly impaired the incorporation of 5-[14CH3]-tetrahydrofolate and [1-14C] propionic acid by intact cells, consistent with inhibition of methionine synthase and methylmalonyl-CoA mutase. A substantial proportion of 5-[14CH3]-tetrahydrofolate uptake could not be suppressed by methionine and may, therefore, have occurred outside of the methionine synthase pathway. These findings are the first indication that cyanocobalamin [c-lactam] antagonizes vitamin B12 in vitro and causes cell death from methionine deficiency. The model should be valuable for investigating the biochemical pathology of vitamin B12-deficient hemopoiesis. The results suggest that methylfolate is not trapped when methionine synthase is inhibited in HL60 cells, but they do not disprove the methylfolate trap hypothesis as applied to normal blood cells.
| |
INTRODUCTION |
THERE HAS HITHERTO been no convenient in vitro model in which to study the actions of vitamin B12 at the cellular level. The clinical effects of vitamin B12 deficiency include megaloblastic anemia, demyelination, neuropsychiatric abnormalities, and raised blood homocysteine concentrations, which may cause arterial and venous thrombosis.1-6 The relationship between the known biochemistry of vitamin B12 and these clinical manifestations, particularly the megaloblastic anemia and the demyelination, remains poorly understood.
Vitamin B12 is required for two biochemical reactions in humans: the methylation of homocysteine to methionine and the isomerization of methylmalonyl-CoA to succinyl-CoA, neither of which is directly concerned with DNA synthesis.7 Because the megaloblastic anemia that occurs in patients with a deficiency of vitamin B12 is characterized by abnormal DNA synthesis, it has been difficult to find a biochemical explanation. A number of hypotheses have been proposed, including methylfolate trapping, failure of folate polyglutamate synthesis, and misincorporation of uracil into DNA, but none is entirely satisfactory.8-12 Similarly, the biochemical relationship between vitamin B12 deficiency and demyelination remains unclear, although a failure of cellular methylation secondary to impaired methionine synthesis may be responsible.13
A tissue culture model of vitamin B12 deficiency would help to elucidate these biochemical problems. Serum contains protein-bound vitamin B12, so that under normal tissue culture conditions, in which the media are supplemented with serum, deficiency cannot be achieved by simple means. Recently, a number of cobalamin analogs were subjected to in vivo testing in rats. Some of them caused marked elevations in the serum levels of homocysteine and methylmalonic acid, suggesting vitamin B12 antagonism.14 Among the most active of these compounds was hydroxocobalamin [c-lactam], a B-ring derivative formed when cobalamin is heated in alkaline solution. The closely related compound, cyanocobalamin [c-lactam], was therefore examined in tissue culture, for the purpose of developing a model of vitamin B12-deficient hematopoiesis.
| |
MATERIALS AND METHODS |
Cell culture and growth media.
HL60 cells were obtained from the American Typed Culture Collection (Rockville, MD). This cell line derives from a human myeloid leukemia and was chosen because, like normal cells and in contrast with some tumor cell lines, it was able to grow in the absence of methionine, when provided with homocysteine, vitamin B12, and a source of folate.15-17
RPMI 1640 was obtained free from vitamin B12, folic acid, and methionine. "Met" medium was supplemented with 200 nmol/L 5-methyltetrahydrofolate, 3.7 nmol/L vitamin B12 (standard vitamin B12 ) 100 µmol/L L-methionine, 5 mg/L gentamicin, 5% dialyzed human serum, and 5% dialyzed fetal bovine serum. "Hcy" medium contained 200 µmol/L L-homocysteine thiolactone instead of methionine. Cyanocobalamin [c-lactam] and additional vitamin B12 were used at a concentration of 7.4 µmol/L. Where indicated, pteroylglutamic acid was used instead of 5-methyltetrahydrofolate. Higher concentrations of both folates were used in some experiments. Where indicated, ascorbic acid at 284 µmol/L was also present in the culture medium. Cultures were performed in the dark, and medium changes were made every 48 hours.
L-homocysteine thiolactone was chosen in preference to homocysteine, because homocysteine in its reduced form is toxic to cells in culture, whereas the thiolactone is not, and there are data indicating that it is readily metabolized to homocysteine, which can then participate in the methionine synthase reaction.18-20 It has been shown repeatedly to support cell growth in the absence of methionine when the cultures contain vitamin B12 and 5-methyltetrahydrofolate.17,18,21 A total of 200 µmol/L L-cystine or L-cysteine were unable to support cell growth in the presence of vitamin B12 and 5-methyltetrahydrofolate with or without ascorbic acid at 284 µmol/L.
Dialysis of serum.
Human and bovine sera were dialyzed in Spectra/Por cellulose ester wet membrane tubing with a molecular weight cut-off of 1,000 (Spectrum Inc, Houston, TX) for 24 hours at 4°C against two changes of normal saline and sterilized by filtration.
Preparation of cyanocobalamin [c-lactam].
A solution of cyanocobalamin at 5 mg/mL in 0.1 mol/L sodium hydroxide was heated to 100°C for 10 minutes, cooled, and neutralized with potassium dihydrogen phosphate. The cobalamins were adsorbed onto a C18 column (Waters Sep-Pak; Waters Assoc, Milford, MA), washed with water, eluted with methanol, evaporated to dryness, and dissolved in water. The carboxylic acids of vitamin B12 were removed on an anion exchange column (AG1-X; Bio-Rad, Missauga, Ontario, Canada), and the resulting solution of cobalamins was concentrated on a Sep-Pak. Purification was performed by paper chromatography (butan-2-ol 880 mL/glacial acetic acid 8.2 mL/hydrogen cyanide 6.2 mmol/water to saturation [approximately 425 mL]). The cyanocobalamin [c-lactam] band was cut from the strip, eluted in water, and concentrated using a Sep-Pak. The concentrations of the cobalamin solutions were determined by spectrophotometry in 0.1 mol/L KCN.
Purity of the cyanocobalamin [c-lactam] preparation.
Paper chromatography in butan-2-ol (1 L containing 2 mL aqueous ammonia [d = 0.88] and 1 mL 4% aqueous hydrogen cyanide) was performed. Under these conditions, cyanocobalamin [c-lactam] has RF 1.15 relative to vitamin B12.22 The preparation gave a single band in the expected position. High performance liquid chromatography (HPLC) was performed in H2O:acetic acid:isopropanol (90:1:9) on a Waters µBondapak C18 reverse phase column (10 µm particle size, 300 × 3.9 mm internal diameter) using a flow rate of 0.3 mL/min. The cobalamin solutions were injected in a volume of 10 µL containing approximately 1 nmol and detected by their absorbance at 365 nm.23 The preparation gave a single peak (retention time, 19.05 minutes) in a clearly different position from that of cyanocobalamin (retention time, 22.06 minutes).
Preparation of purified 5-methyltetrahydrofolic acid.
5-methyltetrahydrofolate was obtained as the disodium salt (Sigma Chemical Co, St Louis, MO) and dissolved in 0.2 mol/L ammonium acetate containing 10 mmol/L 2-mercaptoethanol. Two milligrams was placed on a 40 × 1-cm column of DEAE-Sephadex A-25 equilibrated in 0.2 mol/L ammonium acetate containing 10 mmol/L 2-mercaptoethanol. The material was eluted in the dark at 4°C using a linear gradient of ammonium acetate containing 10 mmol/L 2-mercaptoethanol. A total of 200 mL of 0.2 mol/L ammonium acetate was placed in the mixing chamber, and 200 mL of 2 mol/L ammonium acetate was placed in the reservoir. The flow rate was 10 mL/h, and fractions of 2.5 mL were collected. Absorbance was recorded in the 235 to 340 nm range. The concentration of 5-methyltetrahydrofolate was determined by spectrophotometry, and the solution lyophilized. Finally, the purified 5-methyltetrahydrofolate was dissolved to 0.1 mg/mL in 6 mg/mL ascorbic acid and kept in liquid nitrogen.24
The limiting concentration of 5-methyltetrahydrofolate and pteroylglutamic acid.
Cells were cultured in vitamin B12-, folate-, and methionine-free RPMI 1640 supplemented with 3.7 nmol/L vitamin B12, 100 µmol/L L-methionine, 10% nondialyzed fetal bovine serum, and various concentrations of 5-methyltetrahydrofolate or pteroylglutamic acid. Deoxyuridine suppression tests were performed in microtiter plates as previously described, and the minimum concentration of 5-methyltetrahydrofolate or pteroylglutamic acid needed to maintain normal deoxyuridine suppression was established as 200 nmol/L for both folates.25 This concentration was used in all subsequent experiments, except where otherwise stated.
Incorporation of 5-[14CH3]-tetrahydrofolate.
The incorporation of 5-[14CH3]-tetrahydrofolate by intact cells into trichloroacetic acid (TCA)-precipitable material was taken to reflect the activity of methionine synthase. 5-[14CH3]-tetrahydrofolic acid (barium salt, 59 mCi/mmol) was obtained from Amersham International (Bucks, UK) and dissolved in Hank's balanced salt solution (HBSS) containing 284 µmol/L ascorbic acid to yield a 50 µCi/mL solution. For the assay, 80 µL of this label was added to 4 mL of either test or control medium. Test medium was vitamin B12-, folate-, and methionine-free RPMI 1640 containing L-homocysteine thiolactone 200 µmol/L and ascorbic acid 284 µmol/L. Control medium contained 100 µmol/L methionine instead of homocysteine.20
The cells were grown for several weeks in their stated culture medium until the time of assay. Between 106 and 107 cells were washed three times in HBSS and suspended to 0.5 mL in both test and control media. A total of 50 µL dialyzed fetal calf serum was added to each culture. After 24 hours of incubation at 37°C in 5% CO2, 1.5 mL ice-cold phosphate-buffered saline (PBS) was added to each well and 200 µL was removed for cell counting. The remaining cells were washed twice in ice-cold PBS, and then 2 mL ice-cold 5% TCA was added for 15 minutes. The resulting precipitate was washed three times in ice-cold TCA and then dissolved in 2 mL 1 N NaOH. A total of 1.5 mL of this was neutralized with 90 µL glacial acetic acid and counted in a liquid scintillation counter using the external standard ratio to convert from counts per minute to disintegrations per minute. The results were expressed as pmol 5-[14CH3]-tetrahydrofolic acid incorporated per 106 cells per hour. The uptake in control wells (the non-methionine-suppressible uptake) was also recorded.
Incorporation of [1-14C] propionic acid.
The incorporation of [1-14C] propionic acid by intact cells into TCA-precipitable material was taken to reflect the activity of methylmalonyl-CoA mutase. [1-14C] propionic acid (sodium salt, 51 mCi/mmol) was obtained from NEN Research Products (Wilmington, DE) as an ethanol solution 100 µCi/mL, and diluted to 25 µCi/mL in HBSS. The original method was modified because the cells survived poorly in HBSS. The cells were grown for several weeks in their stated culture medium until the time of assay. A total of 106 to 107 cells were then incubated in 0.5 mL of their specific culture medium with 20 µL label, giving a final concentration of 1 µCi/mL. After 24 hours at 37°C in 5% CO2, the reaction was stopped with ice-cold PBS and the cells prepared for counting as for the incorporation of 5-[14CH3]-tetrahydrofolate. The results were expressed as picomols of [1-14C] propionic acid incorporated per 106 cells per hour.26
| |
RESULTS |
In "Hcy" medium and dialyzed serum, cyanocobalamin [c-lactam] caused cell death within 96 hours in cells cultured with standard concentrations of vitamin B12. Additional vitamin B12 prevented this cell death and restored the growth rate (Fig 1). The cytotoxic effect of cyanocobalamin [c-lactam] was not seen with nondialyzed serum except for some slowing of growth in "Hcy" medium over the first few days of culture. High concentrations of 5-methyltetrahydrofolate (up to 20 µmol/L) did not reverse the cytotoxic effects of cyanocobalamin [c-lactam].
View larger version (14K):
[in this window]
[in a new window]
| Fig 1.
The cytotoxic effect of cyanocobalamin [c-lactam] on HL60 cells. "Hcy" medium was RPMI 1640 without methionine and without folic acid, containing L-homocysteine thiolactone at 200 µmol/L, 5-methyltetrahydrofolate at 200 nmol/L, vitamin B12 at 3.7 nmol/L, 5% dialyzed human serum, and 5% dialyzed fetal bovine serum. Cyanocobalamin [c-lactam] and additional vitamin B12 were used at 7.4 µmol/L. Cyanocobalamin [c-lactam] caused growth arrest followed by cell death, and this effect was reversed by additional concentrations of vitamin B12 . In nondialyzed serum, cell death did not occur (data not shown). High concentrations of 5-methyltetrahydrofolate (up to 20 µmol/L), did not protect the cells against the inhibitor (data not shown).  , "Hcy" medium alone;  , "Hcy" plus c-lactam;  , "Hcy" plus additional vitamin B12 ;  , "Hcy" plus c-lactam and additional vitamin B12 .
|
|
The growth rate of cells in "Met" medium containing 5-methyltetrahydrofolate and dialyzed serum was unaffected by cyanocobalamin [c-lactam] during 4 months of continuous culture (Fig 2). To ensure that the prolonged growth of cells in "Met" medium containing cyanocobalamin [c-lactam] was not facilitated by nonenzymatic oxidation of the 5-methyltetrahydrofolate and subsequent uptake of the oxidized folate via a nonmethionine synthase pathway, the cell growth experiments were repeated in the presence of ascorbic acid at 284 µmol/L. The results were identical (Fig 3).
View larger version (13K):
[in this window]
[in a new window]
| Fig 2.
Methionine protects against the cytotoxic effect of cyanocobalamin [c-lactam] on HL60 cells. "Met" medium was RPMI 1640 without L-homocysteine thiolactone and without folic acid containing methionine at 100 µmol/L, 5-methyltetrahydrofolate at 200 nmol/L, vitamin B12 at 3.7 nmol/L, 5% dialyzed human serum, and 5% dialyzed fetal bovine serum. Cyanocobalamin [c-lactam] (7.4 µmol/L) and additional concentrations of vitamin B12 (7.4 µmol/L) had no effect on the doubling time. , "Met" medium alone; , "Met" plus c-lactam; , "Met" plus additional vitamin B12 ; , "Met" plus c-lactam and additional vitamin B12 .
|
|
View larger version (13K):
[in this window]
[in a new window]
| Fig 3.
Ascorbic acid does not cause cyanocobalamin [c-lactam] to develop a cytotoxic effect on HL60 cells grown in methionine. "Met" medium was RPMI 1640 without L-homocysteine thiolactone and without folic acid, containing methionine at 100 µmol/L, 5-methyltetrahydrofolate at 200 nmol/L, vitamin B12 at 3.7 nmol/L, 5% dialyzed human serum, and 5% dialyzed fetal bovine serum. Ascorbic acid was used at 284 µmol/L, and cyanocobalamin [c-lactam] at 7.4 µmol/L. Cyanocobalamin [c-lactam] does not prolong the doubling time in the presence of ascorbic acid, which stabilizes 5-methyltetrahydrofolate. This suggests that spontaneous oxidation of 5-methyltetrahydrofolate to a form that can bypass methionine synthase and enter cellular folate pools directly when the functions of vitamin B12 are inhibited is not the reason why cells continue to proliferate in the presence of cyanocobalamin [c-lactam] and methionine. , "Met" medium plus ascorbate; , "Met" plus ascorbate and c-lactam; , "Met" plus ascorbate and additional vitamin B12 ; , "Met" plus c-lactam and additional vitamin B12 .
|
|
Pteroylglutamic acid did not prevent the cytotoxic effects of cyanocobalamin [c-lactam] and, in fact, rendered cells in "Hcy" medium more susceptible to the inhibitor. Whereas 5-methyltetrahydrofolate was able to support long-term cell growth in "Hcy" medium and standard concentrations of vitamin B12, pteroylglutamic acid could not do this. The cells grew normally for approximately 10 days, after which growth ceased and the cells died. Additional vitamin B12 supplements maintained viability and allowed continued growth (Fig 4). High concentrations of pteroylglutamic acid (up to 20 µmol/L) did not reverse the cytotoxicity of the inhibitor.
View larger version (15K):
[in this window]
[in a new window]
| Fig 4.
Pteroylglutamic (folic) acid fails to protect HL60 cells against cyanocobalamin [c-lactam]. "PGA-Hcy" medium was RPMI 1640 without methionine and without folic acid, containing L-homocysteine thiolactone at 200 µmol/L, pteroylglutamic acid at 200 nmol/L, vitamin B12 at 3.7 nmol/L, and dialyzed serum. Cyanocobalamin [c-lactam] at 7.4 µmol/L caused growth arrest followed by cell death, and this effect was reversed by additional concentrations of vitamin B12 (7.4 µmol/L). High concentrations of pteroylglutamic acid (up to 20 µmol/L) did not reverse the cytotoxicity (data not shown). Pteroylglutamic acid, a nonmethylated folate, fails to prevent the cell death caused by cyanocobalamin [c-lactam]. Methyl group trapping is, therefore, not the cause of the cytotoxic effect of the inhibitor. , "PGA-Hcy" medium alone; , "PGA-Hcy" plus c-lactam; , "PGA-Hcy" plus additional vitamin B12 ; , "PGA-Hcy" plus c-lactam and additional vitamin B12 .
|
|
To determine whether the cytotoxic effect of the inhibitor was caused by methionine deficiency and to gauge whether the protective effect of nondialyzed serum was caused by its methionine content, we observed the effect of adding back small quantities of methionine to HL60 cells grown in "Hcy" medium, dialyzed serum, and cyanocobalamin [c-lactam]. The methionine concentration in culture media containing nondialyzed serum was 2.8 µmol/L. Adding back as little as 2 µmol/L methionine to medium containing dialyzed serum and the inhibitor allowed cells to proliferate, but the full protective effect of methionine did not occur until the concentration exceeded 20 µmol/L (Fig 5). Above this concentration of methionine, cyanocobalamin [c-lactam] did not inhibit cell growth.
View larger version (16K):
[in this window]
[in a new window]
| Fig 5.
The effects of various concentrations of methionine on the growth inhibitory effects of cyanocobalamin [c-lactam] on HL60 cells. "Hcy" culture medium was RPMI 1640 without methionine and without folic acid, containing L-homocysteine thiolactone at 200 µmol/L, 5-methyltetrahydrofolate at 200 nmol/L, vitamin B12 at 3.7 nmol/L, 5% dialyzed human serum and 5% dialyzed fetal bovine serum, to which was added methionine to give the concentrations shown. Cyanocobalamin [c-lactam] was used at 7.4 µmol/L. HL60 cells were grown for 4 weeks under these conditions, and cell counts were performed every 48 hours. The doubling time was calculated from the slope of the regression line between the log of the cell count and the duration of culture. The proliferation rate was calculated as the number of doubling times per 24 hours. Because small concentrations of methionine, equivalent to those present in nondialyzed serum, protect the cells against the inhibitor, its cytotoxicity is caused by methionine deficiency.
|
|
Cyanocobalamin [c-lactam] caused significant impairment of 5-[14CH3]-tetrahydrofolate incorporation when the cells were grown in either "Met" or "Hcy" culture medium (Fig 6). This was reversed by the additional concentrations of vitamin B12 in the culture medium. In the presence of standard concentrations of vitamin B12, the incorporation of 5-[14CH3]-tetrahydrofolate was higher when HL60 cells were grown in "Hcy" than in "Met" medium. When the cells were cultured with the additional concentrations of vitamin B12, 5-[14CH3]-tetrahydrofolate incorporation was stimulated, and this difference was lost.
View larger version (16K):
[in this window]
[in a new window]
| Fig 6.
The effect of cyanocobalamin [c-lactam] on the incorporation of 5-[14CH3]-tetrahydrofolate into TCA-precipitable material by intact HL60 cells. "Hcy" medium was RPMI 1640 without methionine and without folic acid containing L-homocysteine thiolactone at 200 µmol/L, 5-methyltetrahydrofolate at 200 nmol/L, vitamin B12 at 3.7 nmol/L, 5% nondialyzed human serum, and 5% nondialyzed fetal bovine serum. Cyanocobalamin [c-lactam] and additional vitamin B12 were used at 7.4 µmol/L. "Met" medium was the same, except that methionine at 100 µmol/L was used instead of L-homocysteine thiolactone. Nondialyzed serum was used to maintain the viability of cells grown with the inhibitor. The cells were cultured in the specified medium for several weeks until the time of assay, when they were washed and processed in the assay medium as described in the text. Results represent the mean from five experiments. (a) "Hcy" medium alone, (b) "Hcy"+c-lactam, (c) "Hcy"+additional vitamin B12, (d) "Hcy"+c-lactam+additional vitamin B12 , (e) "Met" medium alone, (f ) "Met"+c-lactam, (g) "Met"+additional vitamin B12 , (h) "Met"+c-lactam+additional vitamin B12 . P < .05 (t-test) for (a) versus (b), (b) versus (d), (e) versus (f ), (f ) versus (h), and (a) versus (e). , nonmethionine-suppressible uptake of label; T, 1 SEM: n = 5.
|
|
In an attempt to determine whether some of the incorporation of 5-[14CH3]-tetrahydrofolate might be taking place via a pathway other than methionine synthase, the uptake of label was also determined in the presence of excess methionine in the assay system. Although methionine synthase remains active in vivo in the presence of excess methionine, the dilution of the labeled end product (methionine) by the excess of exogenous unlabeled methionine should greatly reduce the incorporation of label into trichloroacetic acid-precipitable macromolecules, unless the newly synthesized methionine is channeled directly into cellular methylation reactions or protein synthesis, rather than through a general metabolic pool. Substantial uptake of 5-[14CH3]-tetrahydrofolate did indeed continue in the presence of excess methionine, as shown by the solid bars in Fig 6. Only a small proportion of this is nonspecific uptake, because the incorporation in "Hcy" medium with cyanocobalamin [c-lactam] is very low.
The incorporation of [1-14C] propionic acid by HL60 cells was higher when they were cultured in "Met" than "Hcy" medium. Cyanocobalamin [c-lactam] had little effect on cells in "Met" medium, but suppressed [1-14C] propionic acid incorporation by cells grown in "Hcy" medium. The additional vitamin B12 had no effect on cells in "Met" medium, but stimulated incorporation by those in "Hcy" medium (Fig 7).
View larger version (28K):
[in this window]
[in a new window]
| Fig 7.
The effect of cyanocobalamin [c-lactam] on the incorporation of [1-14C] propionic acid into TCA-precipitable material by intact HL60 cells. "Hcy" medium was RPMI 1640 without methionine and without folic acid, containing L-homocysteine thiolactone at 200 µmol/L, 5-methyltetrahydrofolate at 200 nmol/L, vitamin B12 at 3.7 nmol/L, 5% non-dialyzed human serum, and 5% nondialyzed fetal bovine serum. Cyanocobalamin [c-lactam] and additional vitamin B12 were used at 7.4 µmol/L. "Met" medium was the same, except that methionine at 100 µmol/L was used instead of L-homocysteine thiolactone. The medium was supplemented with nondialyzed serum to maintain the viability of cells grown with the inhibitor. The cells were grown for several weeks and then assayed in their culture medium. The results are the mean from three experiments. (a) "Hcy" medium alone, (b) "Hcy" + c-lactam, (c) "Hcy" + additional vitamin B12, (d) "Hcy" + c-lactam + additional vitamin B12 , (e) "Met" medium alone, (f ) "Met" + c-lactam, (g) "Met" + additional vitamin B12, (h) "Met" + c-lactam + additional vitamin B12 . P < .05 (Wilcoxon) for (a) versus (b) and (b) versus (d) only.
|
|
Megaloblastic morphology did not develop at any time during the cell culture period.
| |
DISCUSSION |
These results show that cyanocobalamin [c-lactam] causes growth inhibition and cell death in vitro by antagonizing the functions of vitamin B12. Nonspecific cytotoxicity is excluded by the lack of growth inhibition in the presence of methionine and because the effects are reversed by vitamin B12. Consistent with this hypothesis, cyanocobalamin [c-lactam] inhibited the incorporation of both 5-[14CH3]-tetrahydrofolate and [1-14C] propionic acid, consistent with antagonism of both methionine synthase and methylmalonyl-CoA mutase, reversible by vitamin B12. The data are also consistent with previous observations on the effects of intravenous hydroxocobalamin [c-lactam] in rats, in which it caused elevated serum concentrations of both methylmalonic acid and homocysteine, suggesting antagonism of vitamin B12.14 Cyanocobalamin [c-lactam] is unlikely to be a direct inhibitor of methionine synthase, because it is an efficient cofactor for the apoenzyme in a cell-free system.27 It more probably affects some other aspect of the intracellular metabolism of vitamin B12, such as uptake, transport, or reduction.
Small concentrations of methionine prevented cytotoxicity, and allowed the cells to proliferate at a reduced rate. Methionine at concentrations of 20 µmol/L or more protected cells completely from the lethal effects of cyanocobalamin [c-lactam]. The cells divided at a normal rate for at least 4 months and showed no morphologic evidence of megaloblastosis. This indicates that methionine deficiency is responsible for the early cytotoxic effects of cyanocobalamin [c-lactam] and that, when the methionine concentration in the culture medium exceeds approximately 20 µmol/L, the remethylation of homocysteine is unimportant for cell growth.
Because HL60 cells grew normally for an indefinite period in the presence of cyanocobalamin [c-lactam] when provided with sufficient methionine, it seems reasonable to conclude that they did not develop intracellular folate deficiency secondary to the inhibition of vitamin B12. Previous data in experimental animals with a deficiency of vitamin B12 show that methionine restores the diminished levels of hepatic folates and reduces urinary excretion of formiminoglutamic acid.28-36 The same effect of methionine is seen on formiminoglutamic acid excretion in humans with a deficiency of vitamin B12, and there is also improvement in the impaired incorporation of deoxyuridine into the DNA of bone marrow cells.37,38 However, methionine does not produce hematological responses in patients with vitamin B12 deficiency.39 In the nitrous oxide-treated rat, in which methionine synthase is approximately 85% inhibited, the methyl group of 5-[14CH3]-tetrahydrofolate can be slowly metabolized to CO2 and the folate incorporated into the cell, an effect that is enhanced by methionine.40-42
There has been controversy as to whether methionine acts by relieving a "methylfolate trap" (Fig 8) or whether it promotes metabolism of 5-methyltetrahydrofolate through a pathway alternative to methionine synthase.43 Oxidation of 5-methyltetrahydrofolate to 5,10-methylenetetrahydrofolate by quinonoid dihydrobiopterin has been reported, which is a potential candidate for such a pathway.44 The present results are against the methylfolate trap hypothesis and favor the existence of an alternative pathway, for the following reasons:
View larger version (18K):
[in this window]
[in a new window]
| Fig 8.
The methylfolate trap hypothesis. Reaction (a) is held to be irreversible under physiological conditions so that reaction (b) is the only metabolic escape for methylfolate. When reaction (b) is inhibited by either a deficiency of vitamin B12 or by cyanocobalamin [c-lactam], folate should be trapped as methylfolate. S-adenosyl methionine has a negative effect on reaction (a) so that inhibition of reaction (b) should effectively increase the flow of 5,10-methylene tetrahydrofolate towards methylfolate. CH3-THF, 5-methyl tetrahydrofolate; 5,10-CH2-THF, 5,10-methylene tetrahydrofolate; THF, tetrahdrofolate. Reaction (a), methylene tetrahydrofolate reductase. Reaction (b), methionine synthase.
|
|
(1) The methylfolate trap hypothesis predicts that, when methionine synthase is inhibited, the growth rate and viability of cells should be enhanced when the folate supplement in the medium does not carry a methyl group at the 5 position. Our results were the opposite. Pteroylglutamic acid, a nonmethylated folate, did not rescue cells from the effects of cyanocobalamin [c-lactam], even in very high concentrations, and was unable to support prolonged cell growth in "Hcy" medium.
(2) Methionine also appeared to reverse the effects of cyanocobalamin [c-lactam] on the incorporation of [1-14C] propionic acid, which cannot be explained in terms of a folate effect. This phenomenon has not previously been observed and, if confirmed, is worthy of further study.
(3) There was substantial incorporation of label from 5-[14CH3]-tetrahydrofolate when the assay system contained excess methionine. One explanation for this finding might be that the uptake occurred via a pathway other than methionine synthase, although channeling of the newly synthesized methionine directly into cellular methylation reactions or protein synthesis cannot be excluded.
Although these findings suggest the existence of a pathway for 5-methyltetrahydrofolate incorporation other than through methionine synthase, they do not necessarily indicate that this pathway was responsible for the protective effect of methionine against cyanocobalamin [c-lactam]. Although cells exposed to the lactam appeared to incorporate 5-[14CH3]-tetrahydrofolate through an apparent nonmethionine-suppressible pathway more in "Met" medium than in "Hcy," the difference was not statistically significant. However, the data in nitrous-oxide breathing rats do suggest that methionine might enhance a nonmethionine synthase pathway of 5-methyltetrahydrofolate use.42
High concentrations of vitamin B12 stimulated the incorporation of 5-[14CH3]-tetrahydrofolate in both "Met" and "Hcy" media. Stimulation by vitamin B12 is characteristic of methionine synthase in cell-free assay systems, presumably because unsaturated apoenzyme is present.27 However, studies of methionine synthase in vivo show that the majority (90% to 100%) of the enzyme is bound to vitamin B12.45 This could mean that the standard concentration of vitamin B12 used in our culture media was suboptimal, so that there was insufficient intracellular vitamin B12 to saturate the apoenzyme, but there may also be alternative explanations, because some of the published data are inconsistent with the hypothesis that the effect of vitamin B12 is simply to bind unsaturated apoenzyme.14 Cells grown in "Hcy" medium incorporated more 5-[14CH3]-tetrahydrofolate than those in "Met" medium. This observation is consistent with previous data showing increased methionine synthase activity in cells cultured in the absence of methionine, resulting probably from the synthesis of new enzyme.21
Spontaneous photogenic oxidation of the 5-methyltetrahydrofolate to a form able to bypass methionine synthase and enter the intracellular folate pools directly seems an improbable explanation for the data presented. All cultures were performed in the dark, and ascorbic acid, which is known to retard the oxidation of 5-methyltetrahydrofolate, had no effect on the results.46,47 The oxidation product of 5-methyltetrahydrofolate is 5-methyldihydrofolate, which is stable in solution. This compound can participate in the methionine synthase reaction, but is not a substrate for methylenetetrahydrofolate reductase, and the methyl group, therefore, cannot be oxidized to a level that could directly enter the cellular folate pools.47 Contamination of the 5-methyltetrahydrofolate by other folates able to circumvent the methionine synthase pathway is excluded because it was purified before use.
We conclude that vitamin B12 is effectively antagonized in the present tissue culture model, and that the effects observed can be explained in terms of methionine deficiency. The results suggest that, in malignant HL60 cells, methylfolate is not trapped when methionine synthase is inhibited, and there may be another pathway by which methylfolate is metabolized. Although these metabolic features may be unique to the malignant state and do not disprove the folate trap hypothesis as applied to the normal blood cells on whose cultures it was developed, this model should be useful for investigating the megaloblastic state. It should be possible to manipulate the culture conditions to induce the biochemical and morphological changes of megaloblastosis, which would lead to significant insights into the understanding of megaloblastic change. It should also improve the understanding of one of the pathways of homocysteine metabolism, abnormalities of which are being increasingly recognized as important in the pathogenesis of vascular disease.
| |
FOOTNOTES |
Submitted August 7, 1996;
accepted January 29, 1997.
Supported by a grant from the Gary Magee Memorial Leukemia Research Fund.
Address reprint requests to J.H. Matthews, MB, Department of Medicine, Queen's University, Kingston, Ontario, Canada K7L 3N6.
The publication costs of this article were defrayed in part by page
charge payment. This article must therefore be hearly marked
``advertisment'' in accordance with 18 U.S.C. section 1734 solely to
indicate this fact.
| |
REFERENCES |
1. Chanarin I: The Megaloblastic Anaemias. Oxford, UK, Blackwell, 1990
2. Matthews JH: Cobalamin and folate deficiency in the elderly, in Wickramasinghe SN (ed): Megaloblastic Anaemia. London, UK, Baillière Tindall, 1995, p 679
3.
Lindenbaum J,
Healton EB,
Savage DG,
Brust JC,
Garrett TJ,
Podell ER,
Marcell PD,
Stabler SP,
Allen RH:
Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis.
N Engl J Med
318:1720,
1988[Abstract]
4.
Perry IJ,
Refsum H,
Morris RW,
Ebrahim SB,
Ueland PM,
Shaper AG:
Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men.
Lancet
346:1395,
1995[Medline]
[Order article via Infotrieve]
5.
Fortin LJ,
Genest J Jr:
Measurement of homocyst(e)ine in the prediction of arteriosclerosis.
Clin Biochem
28:155,
1995[Medline]
[Order article via Infotrieve]
6.
den Heijer M,
Koster T,
Blom HJ,
Bos GMJ,
Briet E,
Reitsma PH,
Vandenbroucke JP,
Rosendaal FR:
Hyperhomocysteinemia as risk factor for deep-vein thrombosis.
N Engl J Med
334:759,
1996[Abstract/Free Full Text]
7. Cooper BA: The assay of cobalamin-dependent enzymes: Their utilization for evaluation of cobalamin metabolism, in Hall CA (ed): The Cobalamins. Edinburgh, UK, Churchill Livingstone, 1983, p 165
8.
Metz J,
Kelly A,
Swett VC,
Waxman S,
Herbert V:
Deranged DNA synthesis by bone marrow from vitamin B-12-deficient humans.
Br J Haematol
14:575,
1968[Medline]
[Order article via Infotrieve]
9.
Deacon R,
Perry J,
Lumb M,
Chanarin I:
Formate metabolism in the cobalamin-inactivated rat.
Br J Haematol
74:354,
1990[Medline]
[Order article via Infotrieve]
10.
Deacon R,
Perry J,
Lumb M,
Chanarin I:
Cobalamin inactivation induces formyltetrahydrofolate synthetase.
FEBS Lett
263:303,
1990[Medline]
[Order article via Infotrieve]
11.
Perry J,
Lumb M,
Van der Westhuyzen J,
Fernandes-Costa F,
Metz J,
Chanarin I:
Utilization of [2-14C]tetrahydropteroylglutamic acid and 5-[G-3H]methyltetrahydropteroylglutamic acid as substrates for folate polyglutamate synthesis in fruit bats: Effect of vitamin B-12-deficiency.
Biochim Biophys Acta
629:566,
1980[Medline]
[Order article via Infotrieve]
12.
Wickramasinghe SN,
Fida S:
Bone marrow cells from vitamin B12- and folate-deficient patients misincorporate uracil into DNA.
Blood
83:1656,
1994[Abstract/Free Full Text]
13.
Surtees R:
Biochemical pathogenesis of subacute combined degeneration of the spinal cord and brain.
J Inherit Metab Dis
16:762,
1993[Medline]
[Order article via Infotrieve]
14.
Stabler SP,
Brass EP,
Marcell PD,
Allen RH:
Inhibition of cobalamin-dependent enzymes by cobalamin analogues in rats.
J Clin Invest
87:1422,
1991
15.
Judde JG,
Frost P:
Patterns of methionine auxotrophy in normal and neoplastic cells: The methionine independence of lymphocyte mitogenesis and low frequency of the methionine-dependent phenotype in human tumors.
Cancer Res
48:6775,
1988[Abstract/Free Full Text]
16.
Halpern BC,
Clark BR,
Hardy DN,
Halpern RM,
Smith RA:
The effect of replacement of methionine by homocystine on survival of malignant and normal adult mammalian cells in culture.
Proc Natl Acad Sci USA
71:1133,
1974[Abstract/Free Full Text]
17.
Liteplo RG,
Hipwell SE,
Rosenblatt DS,
Sillaots S,
Lue-Shing H:
Changes in cobalamin metabolism are associated with the altered methionine auxotrophy of highly growth autonomous human melanoma cells.
J Cell Physiol
149:332,
1991[Medline]
[Order article via Infotrieve]
18.
Djurhuus R,
Svardal AM,
Ueland PM,
Male R,
Lillehaug JR:
Growth support and toxicity of homocysteine and its effects on methionine metabolism in non-transformed and chemically transformed C3H/10T1/2 cells.
Carcinogenesis
9:9,
1988[Abstract/Free Full Text]
19.
McCully KS:
Homocysteine thiolactone metabolism in malignant cells.
Cancer Res
36:3198,
1976[Abstract/Free Full Text]
20.
Mellman I,
Willard HF,
Youngdahl-Turner P,
Rosenberg LE:
Cobalamin coenzyme synthesis in normal and mutant human fibroblasts. Evidence for a processing enzyme activity deficient in cblC cells.
J Biol Chem
254:11847,
1979[Free Full Text]
21.
Kamely D,
Littlefield JW,
Erbe RW:
Regulation of 5-methyltetrahydrofolate: Homocysteine methyltransferase activity by methionine, vitamin B12, and folate in cultured baby hamster kidney cells.
Proc Natl Acad Sci USA
70:2585,
1973[Abstract/Free Full Text]
22. Bonnett R, Cannon JR, Clark VM, Johnson AW, Parker LK, Smith EL, Todd A: Chemistry of the vitamin B 12 group. V. The structure of the chromophoric grouping. J Chem Soc 1158, 1957
23.
Binder M,
Kolhouse JF,
Van Horne KC,
Allen RH:
High-pressure liquid chromatography of cobalamins and cobalamin analogs.
Anal Biochem
125:253,
1982[Medline]
[Order article via Infotrieve]
24.
Nixon PF,
Bertino JF:
Enzymatic preparations of radiolabeled (+)-L-5-methyltetrahydrofolate and (+)-L-5-formyltetrahydrofolate.
Anal Biochem
43:162,
1971[Medline]
[Order article via Infotrieve]
25.
Matthews JH,
Wickramasinghe SN:
A method for performing deoxyuridine suppression tests on microtitre plates.
Clin Lab Haematol
8:61,
1986[Medline]
[Order article via Infotrieve]
26.
Willard HF,
Ambani LM,
Hart AC,
Mahoney MJ,
Rosenberg LE:
Rapid prenatal and postnatal detection of inborn errors of propionate, methylmalonate, and cobalamin metabolism: A sensitive assay using cultured cells.
Hum Genet
34:277,
1976[Medline]
[Order article via Infotrieve]
27.
Kolhouse JF,
Utley C,
Stabler SP,
Allen RH:
Mechanism of conversion of human apo- to holomethionine synthase by various forms of cobalamin.
J Biol Chem
266:23010,
1991[Abstract/Free Full Text]
28.
Vitale JJ,
Hegsted DM:
Effects of dietary methionine and vitamin B12 deficiency on folate metabolism.
Br J Haematol
17:467,
1969[Medline]
[Order article via Infotrieve]
29.
Kutzbach C,
Galloway E,
Stokstad EL:
Influence of vitamin B12 and methionine on levels of folic acid compounds and folate enzymes in rat liver.
Proc Soc Exp Biol Med
124:801,
1967[Medline]
[Order article via Infotrieve]
30.
McGeer PL,
Sen NP,
Grant DA:
Excretion of 4(5)-amino-5(4)-imidazolecarboxamide and formimino-L-glutamic acid in folic acid and vitamin B12 deficient rats.
Can J Biochem
43:1367,
1965
31.
Brown DD,
Silva OL,
Gardiner RC,
Silverman S:
Metabolism of formiminoglutamic acid by vitamin B12- and folic acid-deficient rats fed excess methionine.
J Biol Chem
235:2058,
1960[Free Full Text]
32.
Smith RM,
Osborne-White WS,
Gawthorne JM:
Folic acid metabolism in vitamin B12-deficient sheep. Effects of injected methionine on liver constituents associated with folate metabolism.
Biochem J
142:105,
1974[Medline]
[Order article via Infotrieve]
33.
Thenen SW,
Stokstad EL:
Effect of methionine on specific folate coenzyme pools in vitamin B 12 deficient and supplemented rats.
J Nutr
103:363,
1973
34.
Buehring KU,
Batra KK,
Stokstad EL:
The effect of methionine on folic acid and histidine metabolism in perfused rat liver.
Biochim Biophys Acta
279:498,
1972[Medline]
[Order article via Infotrieve]
35.
Shin YS,
Beuhring KU,
Stokstad EL:
The relationships between vitamin B12 and folic acid and the effect of methionine on folate metabolism.
Mol Cell Biochem
9:97,
1975[Medline]
[Order article via Infotrieve]
36.
Silverman M,
Pitney AJ:
Dietary methionine and the excretion of formiminoglutamic acid by the rat.
J Biol Chem
233:1179,
1958[Free Full Text]
37.
Herbert V,
Sullivan LW:
Formiminoglutamicaciduria in humans with megaloblastic anemia: Diminution by methionine or glycine.
Proc Soc Exp Biol Med
112:304,
1963
38.
Karasawa M,
Yamauchi H,
Omine M,
Maekawa T:
Methionine partially corrects the impaired deoxyribonucleic acid synthesis of B12-deficient megaloblastic bone marrow cells at low concentration.
Jap J Med
25:155,
1986[Medline]
[Order article via Infotrieve]
39.
Rundles W,
Brewer S:
Hematologic responses in pernicious anemia to orotic acid.
Blood
13:99,
1958[Abstract/Free Full Text]
40.
Kondo H,
Osborne ML,
Kolhouse JF,
Binder MJ,
Podell ER,
Utley CS,
Abrams RS,
Allen RH:
Nitrous oxide has multiple deleterious effects on cobalamin metabolism and causes decreases in activities of both mammalian cobalamin-dependent enzymes in rats.
J Clin Invest
67:1270,
1981
41.
Lumb M,
Chanarin I,
Perry J,
Deacon R:
Turnover of the methyl moiety of 5- methyltetrahydropteroylglutamic acid in the cobalamin-inactivated rat.
Blood
66:1171,
1985[Abstract/Free Full Text]
42.
Lumb M,
Deacon R,
Perry J,
Chanarin I:
Oxidation of 5-methyltetrahydrofolate in cobalamin-inactivated rats.
Biochem J
258:907,
1989[Medline]
[Order article via Infotrieve]
43.
Chanarin I,
Deacon R,
Lumb M,
Muir M,
Perry J:
Cobalamin-folate interrelations: A critical review.
Blood
66:479,
1985[Free Full Text]
44. Kaufman S: Some metabolic relationships between biopterin and folate: Implications for the "methyl trap hypothesis." Neurochem Res 16:1031, 1991
45.
Chen Z,
Chakraborty S,
Banerjee R:
Demonstration that mammalian methionine synthases are predominantly cobalamin-loaded.
J Biol Chem
270:19246,
1995[Abstract/Free Full Text]
46. Blakley RL: Chemical and physical properties of pterins and folate derivatives, in The Biochemistry of Folic Acid and Related Pteridines. Amsterdam, The Netherlands, North-Holland, 1969, p 58
47.
Donaldson KO,
Keresztesy JC:
Naturally occurring forms of folic acid.
J Biol Chem
237:3815,
1962[Free Full Text]
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
|
|
Abstract
Introduction
Abstract